Literature DB >> 30977083

Muscle endocrinology and its relation with nutrition.

Cecilia Romagnoli1, Barbara Pampaloni1, Maria Luisa Brandi2.   

Abstract

Recent years have demonstrated clear evidence that skeletal muscle is an active endocrine organ. During contraction of muscle fibers, the skeletal muscle produces and releases, into the blood stream, cytokines and other peptides, called myokines, thanks to which it can both communicate with cells locally within the muscle, in an autocrine and paracrine fashion, or with other distant tissues, exerting its endocrine effects. With the progress of sophisticated technologies, the interest towards the skeletal muscle secretome is rapidly grown and the discovery of new myokines represents a prolific field for the identification of new pharmacological approaches for the management and treatment of many clinical diseases. Considering the importance of the muscle proteome and the cross-talk with other organs, the preservation of a skeletal muscle in good health represents a fundamental aspect in life, especially in ageing. Sarcopenia is the age-dependent loss of skeletal muscle mass and strength, bringing to increases of the risk of adverse outcomes, such as physical disability and poor quality of life, as well as alteration of several hormonal networks. For that reasons, the scientific community has risen its interest to find new interventions to prevent and manage the sarcopenia. Adequate nutrition during ages plays a fundamental role in the health and function of the skeletal muscle and it can represents, alone or in combination with physical exercise, a possible preventive measure against sarcopenia. This review will overview the endocrinology of the skeletal muscle, making a focus on food intake as a strategy for preventing skeletal muscle decay.

Entities:  

Keywords:  Myokine; Nutrition; Protein intake; Sarcopenia; Skeletal muscle endocrinology

Mesh:

Substances:

Year:  2019        PMID: 30977083     DOI: 10.1007/s40520-019-01188-5

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  7 in total

Review 1.  Diabetic sarcopenia: metabolic and molecular appraisal.

Authors:  Hayder A Giha; Osman A O Alamin; Mai S Sater
Journal:  Acta Diabetol       Date:  2022-04-16       Impact factor: 4.280

Review 2.  Interactions between Muscle and Bone-Where Physics Meets Biology.

Authors:  Marietta Herrmann; Klaus Engelke; Regina Ebert; Sigrid Müller-Deubert; Maximilian Rudert; Fani Ziouti; Franziska Jundt; Dieter Felsenberg; Franz Jakob
Journal:  Biomolecules       Date:  2020-03-10

3.  Characterization of Skeletal Muscle Endocrine Control in an In Vitro Model of Myogenesis.

Authors:  Cecilia Romagnoli; Roberto Zonefrati; Preeti Sharma; Marco Innocenti; Luisella Cianferotti; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2020-02-27       Impact factor: 4.333

4.  Association of a Low Geriatric Nutritional Risk Index with Higher Adverse Outcome in the Elderly Patients with Fall Injuries: Analysis of a Propensity Score-Matched Population.

Authors:  Szu-Wei Huang; Shih-Min Yin; Ching-Hua Hsieh
Journal:  Risk Manag Healthc Policy       Date:  2021-04-01

5.  Age-Specific Association Between Handgrip Strength and Nutritional Quality in Korean Men: A Nationwide Cross-Sectional Study.

Authors:  Woo-Young Shin; Jung-Ha Kim
Journal:  Am J Mens Health       Date:  2021 Nov-Dec

6.  Inhibition of Lipopolysaccharide-Induced Inflammatory and Oxidative Responses by Trans-cinnamaldehyde in C2C12 Myoblasts.

Authors:  Cheol Park; Hyesook Lee; Suhyun Hong; Ilandarage Menu Neelaka Molagoda; Jin-Woo Jeong; Cheng-Yun Jin; Gi-Young Kim; Sung Hyun Choi; Sang Hoon Hong; Yung Hyun Choi
Journal:  Int J Med Sci       Date:  2021-04-23       Impact factor: 3.738

7.  MiR-1290 promotes myoblast differentiation and protects against myotube atrophy via Akt/p70/FoxO3 pathway regulation.

Authors:  Ji Che; Cuidi Xu; Yuanyuan Wu; Peiyu Jia; Qi Han; Yantao Ma; Xiaolei Wang; Yongjun Zheng
Journal:  Skelet Muscle       Date:  2021-03-15       Impact factor: 4.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.